![](/img/cover-not-exists.png)
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
M. F. Botteman, M. Meijboom, I. Foley, J. M. Stephens, Y. M. Chen, S. KauraVolume:
12
Language:
english
Pages:
14
DOI:
10.1007/s10198-010-0272-0
Date:
December, 2011
File:
PDF, 1.75 MB
english, 2011